Overview

A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

Status:
Not yet recruiting

Trial end date:
2027-05-30

Target enrollment:

Participant gender:

Summary

To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).

Phase:

Phase 4

Details

Lead Sponsor:

Yale University

Treatments:

Adrenergic beta-Antagonists
Calcium
Calcium Channel Blockers